Tenderwize
Zurück zur Suche

Open House contract for Glycopyrronium bromide/Formoterol

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2027 · 340 days left·Open·Supplies
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-18 - Glycopyrroniumbromid/Formoterol (Wirkstoffkombination)

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

46 / 100

Komplexität

58 / 100

Risikofaktoren

The notice says contracts cannot be submitted via the procurement portal; they must be sent by email with qualified ele...

Only pharmaceutical companies meeting the AMG-based eligibility conditions for the specific medicines may participate.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Conclude supply contracts for pharmaceutical products relating to Glycopyrroniumbromid/Formoterol.
  • Provide the relevant medicines for the German market nationwide.
Vollständige Zusammenfassung anzeigen

Open House supply arrangement for pharmaceutical products concerning Glycopyrroniumbromid/Formoterol. The Techniker Krankenkasse seeks to conclude non-exclusive contracts with all suitable pharmaceutical companies under uniform conditions; no individual negotiations are held. The notice states that participation documents are only provided to companies that market or credibly intend to market the relevant medicines during the contract period. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. The procedure is described as not being a public procurement contract in the usual sense, so standard procurement review routes are said not to apply.

Risiken

The notice says contracts cannot be submitted via the procurement portal; they must be sent by email with qualified ele...

Only pharmaceutical companies meeting the AMG-based eligibility conditions for the specific medicines may participate.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Applicant must be a pharmaceutical company within the meaning of § 4 Abs. 18 AMG for the relevant medicines.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicines or otherwise be entitled to place them on the market in its own name.

Auftraggeber

Ort

Hamburg, DEU

Kennung

992-80116-93

Tätigkeit

Health

Lose (1)

LOT-0001

Open House contract for Glycopyrronium bromide/Formoterol

Supply arrangement for the drug combination Glycopyrroniumbromid/Formoterol. Scope is nationwide in Germany. The lot is an Open House Originale contract with uniform terms, no exclusivity, and no individual negotiations. The contract can be joined at any time during the contract period, subject to the stated eligibility conditions and document requirements. Source: structured data and XML notice.

SuppliesEU fundedElectronic submission

Ort

DE600, Germany

Dauer

Jul 2025 - Jul 2027

Kategorie

Pharmaceutical products

Frist

Deadline Jul 30, 2027

Vergabedetails

Veröffentlichungsdatum
11 May 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
299868-2025

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3